National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

Haemophilus influenzae b vaccine
A vaccine against serotype b of the Gram-negative bacterium H. influenzae (Hib). Hib vaccines contain polysaccharide-protein conjugate antigens that produce greater host immune responses than first-generation purified polysaccharide vaccine. These vaccines may differ with regard to use of protein carriers, polysaccharides, diluents, and preservatives. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Haemophilus b conjugate vaccine
Haemophilus b oligosaccharide conjugate vacccine
Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-OMP)
Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-T)
Hib TITER vaccine
US brand names:ActHIB
HibTITER
PedvaxHIB



Previous:guanazole, gusperimus, GVAX lung cancer vaccine, Gyne-Lotrimin, Haelan 951
Next:Haldol, Halodrin, halofuginone hydrobromide, haloperidol, Halotestin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov